The Canadian Underage Substance Use Prevention Trial (CUSP)

April 23, 2026 updated by: Patricia Conrod, St. Justine's Hospital
Despite having made some strides with respect to reducing adolescent drinking rates, illicit substance use and substance use disorders (SUDs) remain significantly above national targets for health promotion and disease prevention in Canada and the United States. Now, more than ever, there is a pressing need for effective substance abuse prevention in Canada, particularly for those most at risk of developing substance use problems including prescription drug misuse. Clearly, new approaches to prevention (with lower numbers needed to treat) are needed and which translate new research on addiction vulnerability to personalised prevention and early intervention. The PreVenture Program involves brief cognitive-behavioural interventions targeting personality traits from a neurocognitive perspective. While the personality-targeted approach has been shown to be effective in reducing most substance use behaviors, it has yet to be evaluated for its impact on uptake of prescription drug misuse in adolescents. The Canadian Underage Substance use Prevention (CUSP) Trial aims to evaluate the long-term effects of a personality-targeted school-based prevention program on delaying the onset of drug and alcohol use in adolescence over three years across Canada. This is a hybrid effectiveness [E] and implementation-facilitation [IF] trial on delaying the onset of drug and alcohol use in adolescence. In the [E] part, the effects of a personalized prevention program will be tested against usual school-based prevention curricula. PreVenture is delivered through a TtT implementation model with or without [IF], e.g. with ongoing supervision and web-based support. The [IF] package is designed to support long-term sustainability of PreVenture after a community accesses PreVenture training.

Study Overview

Detailed Description

Aim:

To evaluate the effectiveness and implementation of the PreVenture program on reducing substance-related problems and substance use behaviours in adolescence when delivered in real-world school settings using a train-the-trainer (TtT) model, with and without implementation facilitation.

Questions:

This hybrid Type II effectiveness-implementation trial examines whether a personality-targeted prevention program, delivered through a TtT model, reduces substance-related problems and substance use behaviours among high-risk adolescents in routine school settings. In the effectiveness [E] part, the effects of PreVenture will be compared with usual school-based prevention curricula. PreVenture is delivered through a TtT implementation model with or without implementation facilitation [IF], consisting of ongoing coaching, supervision, and web-based support. The [IF] package is designed to support long-term sustainability of PreVenture after a community accesses PreVenture training.

[E] questions: Does the PreVenture intervention, when delivered through a TtT model (with or without IF), reduce the severity of substance-related problems among high-risk secondary school students compared with treatment as usual (primary)? Does the intervention reduce substance-related problems, binge drinking, cannabis use, illicit drug use, and non-medical prescription drug use at approximately 12 and 24 months post-baseline (secondary)? Does the intervention demonstrate sustained effects across available follow-up assessments (secondary)?

[IF] questions: Does the addition of the implementation facilitation [IF] package improve implementation outcomes (feasibility, reach, fidelity, sustainability) compared with the standard PreVenture TtT model?

Design:

Three sites (Nova Scotia, Ontario, British Columbia) participated in the trial. Each site recruited up to 9-10 high schools, randomised to one of three intervention conditions. Twenty-nine schools were randomised in total. Schools that withdrew prior to the baseline survey were replaced with another school assuming the same randomised intervention condition.

  1. Treatment-As-Usual (TAU) control: standard curriculum and mental health care.
  2. TtT PreVenture delivered using a train-the-trainer model (PTtT): Locally certified trainers provide structured PreVenture training to school-based professionals, who subsequently deliver the intervention to students.
  3. TtT PreVenture with Implementation Facilitation (PTtT+IF): In addition to PTtT, schools receive enhanced implementation support, including: a) involvement of youth in promoting the program, b) ongoing coaching and supervision sessions for group facilitators, and c) access to easy-to-use performance metrics.

Each school screened all consenting Grade 10 students using the Substance Use Risk Profile Scale (SURPS). A small number of schools also screened Grade 9 students as part of local implementation decisions. Students were enrolled across three successive cohorts. Cohort 1 completed follow-up assessments at approximately 12 and 24 months post-baseline; Cohort 2 completed a single follow-up at approximately 12 months post-baseline; Cohort 3 contributed baseline screening and implementation data only and did not complete post-baseline effectiveness assessments.

The primary analysis population includes high-risk students - defined as scoring at least 0.9 standard deviations above school-based norms on one or more SURPS subscales - from Cohorts 1 and 2 attending randomised schools that contributed at least one post-baseline assessment. Students will be analysed according to their school's randomised assignment, regardless of intervention participation or level of follow-up completion.

The PreVenture program is a personality-targeted prevention program designed to help youth understand their target personality trait and develop adaptive coping strategies using motivational and cognitive restructuring techniques. Four personality-specific motivational pathways to substance misuse are targeted: hopelessness, anxiety sensitivity, impulsivity, and sensation seeking. PreVenture involves two 90-minute group sessions, with one week separating each session. Sessions use structured manuals incorporating psychoeducational, motivational enhancement, and cognitive-behavioural therapy components.

Main Hypotheses:

[E] Primary hypothesis: Among adolescents identified as high risk based on SURPS personality profiles, assignment to PreVenture delivered via a TtT model (with or without IF) will reduce the probability of screening positive on the CRAFFT tool (score ≥2) at follow-up compared with assignment to treatment as usual.

[E] Secondary hypotheses:

  1. Assignment to PreVenture (PTtT or PTtT+IF) will reduce substance-use behaviours at follow-up, including binge drinking, cannabis use, illicit drug use, and non-medical use of prescription drugs, compared with treatment as usual.
  2. Intervention effects on substance-related problem severity and substance-use behaviours will be sustained across available follow-up assessments.

[IF] Outcomes:

  1. Fidelity: Schools randomised to receive IF will demonstrate higher implementation fidelity during delivery of PreVenture sessions compared with schools receiving PreVenture without IF.
  2. Sustainability: Schools in the IF condition will be more likely to continue delivering PreVenture beyond the initial implementation period.
  3. Reach: Schools in the IF condition will deliver both PreVenture sessions to a greater proportion of eligible high-risk students compared with schools without IF.
  4. Uptake of IF components: Among IF schools, engagement with individual IF components (youth promotion activities, ongoing coaching and supervision, and use of performance metric tools) will be described to characterise interest in and utilisation of the different implementation support strategies.
  5. Student feedback: Students in the IF condition will report higher perceived alignment between session content and core PreVenture learning goals, reflecting higher-quality implementation.

Data analyses strategy for [E]:

Primary and secondary effectiveness analyses will include all students identified as high risk at baseline using the SURPS who attended randomised schools contributing at least one post-baseline cluster-level assessment, and who contributed at least one post-baseline individual outcome assessment. Students will be analysed according to the randomised assignment of their school, regardless of intervention participation or level of follow-up completion. For effectiveness analyses, the two intervention arms (PTtT and PTtT+IF) will be pooled into a single arm, as the content of the PreVenture intervention is identical across delivery conditions.

The primary effectiveness outcome is CRAFFT-positive screening, defined as a CRAFFT score ≥2. The primary estimand is the average treatment effect of assignment to PreVenture across all post-baseline assessments, estimated using mixed-effects logistic regression models pooling all available follow-up waves. Models will include a school-level random intercept, an individual-level random intercept (dropped if variance is estimated at zero), and fixed effects for treatment condition, wave, cohort, baseline CRAFFT score, and additional baseline covariates (age, sex, province, SURPS subscale scores). Results will be reported as adjusted odds ratios with 95% confidence intervals, alongside marginal predicted probabilities and risk differences estimated via marginal standardisation. The primary hypothesis will be evaluated at a two-sided α = 0.05. Given the small number of contributing clusters, the Kenward-Roger correction will be applied to adjust degrees of freedom and standard errors.

Secondary behavioural outcomes - including binge drinking, cannabis use, illicit drug use, and non-medical prescription drug use - will be analysed using the same model structure. Binary outcomes will use mixed-effects logistic regression; ordinal frequency outcomes will use proportional odds mixed-effects regression.

Secondary analyses will examine: (1) wave-specific treatment effects in Cohort 1 to assess whether intervention effects are sustained over time; and (2) complier average causal effect (CACE) analyses using school-level randomisation as an instrumental variable for session attendance. Secondary analyses are exploratory and no multiplicity adjustment will be applied.

Missing outcome data will be handled using full maximum likelihood estimation under the missing at random (MAR) assumption, incorporating all available repeated measurements without requiring complete cases. A pre-specified inverse probability weighting (IPW) sensitivity analysis will assess the influence of attrition on study conclusions by upweighting students with observed outcomes whose baseline characteristics resemble those lost to follow-up.

Data analysis strategy for [IF]:

Analyses of implementation outcomes will be descriptive and will focus on fidelity, reach, uptake of IF components, sustainability, and student feedback across intervention arms. Implementation outcomes will be summarised for schools randomised to PTtT+IF and compared descriptively with schools receiving PTtT alone. These analyses will draw primarily on data from Cohorts 2 and 3. The trial was not powered for formal inferential testing of implementation outcomes.

The following implementation outcomes will be assessed:

  1. Fidelity and adherence: quality of PreVenture delivery will be assessed using the PreVenture Intervention Fidelity and Adherence (PIFA) scale, summarised by arm and cohort, and reported separately by facilitator type where available.
  2. Reach: the proportion of eligible high-risk students who received both PreVenture sessions will be calculated per school and summarised by arm and cohort.
  3. Uptake of IF components: the proportion of IF schools engaging in youth-promotion activities, coaching and supervision sessions, and use of performance-metric tools will be reported.
  4. Sustainability: the proportion of schools continuing to deliver PreVenture in Cohort 3 will be reported by arm and by whether delivery was school-led or externally supported.
  5. Student feedback: descriptive summaries of student responses to open-ended and precoded questions about intervention content, likes, dislikes, and learning objectives will be reported by arm and cohort.

Structured reflections completed by research staff will be summarised narratively to contextualise quantitative implementation findings and characterise variation in delivery conditions across provinces and cohorts.

Study Type

Interventional

Enrollment (Estimated)

12500

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • British Columbia
      • Kelowna, British Columbia, Canada
        • University of British Columbia Okanagan Campus
    • Nova Scotia
      • Halifax, Nova Scotia, Canada
        • Dalhousie University
    • Ontario
      • Toronto, Ontario, Canada
        • Center for Mental Health and Addicitions
    • Quebec
      • Montreal, Quebec, Canada, H3T 1C5
        • CHU Sainte-Justine Research Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 16 years (Child)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Survey: All year 10 students with youth consent and parental passive or active consent (depending on local site requirements) will be eligible to participate in the survey
  • PreVenture: Eligibility will include consenting to study protocol and scoring 0.9 or more Standard Deviations (SD) above the school's norm on the 23-item Substance Use Risk Profile Scale (SURPS). The SURPS is a 23-item validated tool that assesses four personality dimensions along the internalizing (hopelessness (HOP) and anxiety sensitivity (AS)) and externalizing (impulsivity (IMP) and sensation seeking (SS)) spectrum. It has been shown to predict specific substance use patterns, including cannabis use and non-medical use of prescription drugs. Of those screened in a given year, approximately 1350 (45%) will report elevated personality profiles and will be eligible for intervention.

Exclusion Criteria:

- Students that do not have either the site-specific parental consent/assent or youth consent will not be eligible to participate in the survey or PreVenture

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PreVenture Training (PTtT)
Schools randomized to this arm will identify 4 staff members to participate in a 2-day training workshop + 3 hours of supervised practice and will be provided with access to screening and PreVenture intervention materials through the local trainer. Local trainers will deliver 2-day workshops and then supervise school staff in the delivery of two 90-minute group sessions (for at least one personality profile).

PreVenture TtT model will involve identifying local expert trainers to be trained to train school-based professionals on the PreVenture program. Steps include:

  1. PreVenture Facilitator certification: Trainers participate in training workshops and deliver the program to eligible youth in Cohort 1 and are rated on quality of implementation using the PIFA.
  2. Reliable use of the PIFA: Each trainer demonstrates convergence with the Montreal Team's ratings on a set of previously-recorded PreVenture sessions.
  3. PreVenture Training Workshop Certification: Trainers participate in a one-day TtT workshop to review the main aims and exercises of PreVenture Training. Trainers then record mock TtT sessions in which key components of the PreVenture Training Workshop are delivered to an audience of 4-10 individuals (e.g., class of graduate students). These sessions are rated by the Montreal Team the PreVenture Implementation Fidelity and Adherence-Trainer Scale (PIFA-T).
Other Names:
  • PreVenture
Experimental: PreVenture Training + Implementation Facilitation (PTtT+IF)
Schools randomized this arm will receive the standard PreVenture TtT protocol plus an additional Implementation Facilitation package that will contain 3 new components designed to increase the likelihood that schools will continue to implement the program with high quality and satisfaction: 1) Youth Engagement, 2) ongoing coaching and supervision for Facilitators, and 3) access to easy-to-use performance metrics.

PreVenture TtT model + Implementation Facilitation Package:

  1. Youth advisors identified the role of older youth to support program implementation. Youth will help promote PreVenture to students and families and help Facilitators optimize attendance at sessions.
  2. Trainer-led coaching sessions will focus on enhancing program fidelity and acceptability by Facilitators. 'Best practice' supervision elements from efficacy trials will be integrated. Fidelity and symptom monitoring will be conducted in real-time during program implementation.
  3. Performance metrics have been developed based on youth qualitative feedback to PreVenture sessions in previous trials. Analysis indicates key responses that are predictive of students most likely to benefit from PreVenture on 12-month substance use outcomes and indicates the extent to which Facilitator's interventions are leaving students with impressions consistent with positive long-term outcomes.
Other Names:
  • PreVenture+IF
No Intervention: Control (TAU)
For schools randomized to this arm, students will have usual access to drug and alcohol prevention through the standard curriculum and mental health care provided through student counseling at the participating schools. The schools will be incentivized to participate in the study with the promise of free PreVenture training and materials in subsequent years of the trial. Information on other drug prevention efforts implemented at the school will be collected, but the randomized design should control for any potential differences between intervention conditions on this random factor.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effectiveness (primary): Risk of substance use problems
Time Frame: Baseline to 24 months

The primary effectiveness outcome is CRAFFT-positive screening, defined as a CRAFFT total score ≥2, indicating elevated risk of substance-related problems. Effectiveness will be assessed by comparing changes in the proportion of adolescents screening CRAFFT-positive in schools randomized to PreVenture (both implementation arms pooled) versus treatment as usual (TAU).

The CRAFFT Screening Test is a short clinical assessment tool designed to screen for substance-related risks and problems in adolescents. CRAFFT stands for the key words of the 6 items in the second section of the assessment - Car, Relax, Alone, Forget, Friends, Trouble. CRAFFT employs a skip pattern: participants whose Part A score is "0" (no use) answer the Car question only of Part B, while those who report any use in Part A also answer Part B's five CRAFFT questions. Each "yes" answer is scored as "1" point and a CRAFFT total score of two or higher identifies elevated risk for a substance use disorder.

Baseline to 24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effectiveness (secondary): Binge drinking
Time Frame: Baseline to 24 months

Any binge drinking among adolescents identified as high risk in schools randomised to PreVenture (both intervention arms pooled) versus TAU.

Binge drinking will be assessed by a sub-item from the Alcohol Use Disorders Identification Test (AUDIT), asking "How often do you have five or more drinks on one occasion?" A binary indicator will be derived, coded 1 if the student responded "Less than monthly", "Monthly", "Weekly", or "Daily or almost daily", and 0 if the student responded "Never". This reflects any binge drinking in the past 12 months.

Baseline to 24 months
Effectiveness (secondary outcome): Cannabis use
Time Frame: Baseline to 24 months

Any cannabis use in the past 12 months among adolescents identified as high risk in schools randomised to PreVenture versus TAU.

Cannabis use will be assessed by asking: "Have you used cannabis in the last 12 months?" [options: yes/no]. A binary indicator will be derived, coded 1 for any use in the past 12 months and 0 for no use.

Baseline to 24 months
Effectiveness (secondary): Non-medical prescription drug use
Time Frame: Baseline to 24 months

Any non-medical prescription drug (NMPD) use in the past 12 months among adolescents identified as high risk in schools randomised to PreVenture versus TAU.

NMPD use will be assessed by asking: "Have you used prescription drugs for non-medical use (without a doctor's prescription) in the last 12 months?" [options: yes/no]. A binary indicator will be derived, coded 1 for any use in the past 12 months and 0 for no use.

Baseline to 24 months
Effectiveness (secondary outcome): Illicit substance use
Time Frame: Baseline to 24 months

Any illicit substance use in the past 12 months among adolescents identified as high risk in schools randomised to PreVenture versus TAU.

Illicit substance use will be assessed by asking whether the student used any of the following substances in the last 12 months: solvents, cocaine, MDMA, methamphetamine, heroin, fentanyl, psilocybin, LSD, steroids, or PCP [options: yes/no for each]. A binary indicator will be derived, coded 1 if the student reported use of any of these substances in the past 12 months and 0 if no substances were reported.

Baseline to 24 months
Implementation Outcomes: Reach
Time Frame: Baseline to 36 months
Proportion of eligible high-risk students completing both Preventure sessions between schools receiving PreVenture by standard Train-the-Trainer (PTtT) vs. PTtT with implementation facilitation (IF) support.
Baseline to 36 months
Implementation Outcomes: Fidelity
Time Frame: Baseline to 36 months
Level of adherence to core program components and overall delivery quality using the PreVenture Intervention Fidelity and Adherence (PIFA) scale between schools receiving PreVenture by standard Train-the-Trainer (PTtT) vs. PTtT with implementation facilitation (IF) support.
Baseline to 36 months
Implementation Outcomes: Student-reported acceptability of PreVenture
Time Frame: Baseline to 36 months
Alignment of student-reported learning reported in brief student feedback surveys with key Preventure goals using the validated performance-metric theme grid between schools receiving PreVenture by standard Train-the-Trainer (PTtT) vs. PTtT with implementation facilitation (IF) support.
Baseline to 36 months
Implementation Outcomes: Uptake of IF components
Time Frame: Baseline to 36 months
Proportion of Preventure + IF schools that engaged with youth-promotion activities, coaching/supervision, and performance-metric tools
Baseline to 36 months
Implementation Outcomes: Sustainability
Time Frame: Baseline to 36 months
Proportion of schools (PreVenture TtT vs. PTtT+IF) that continue to deliver the intervention in Cohort 3 (implementation cohort).
Baseline to 36 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effectiveness (other pre-specified): Frequency of binge drinking
Time Frame: Baseline to 24 months

Frequency of binge drinking among adolescents identified as high risk in schools randomised to PreVenture (both intervention arms pooled) versus TAU.

Frequency of binge drinking will be assessed by a sub-item from the Alcohol Use Disorders Identification Test (AUDIT), asking "How often do you have five or more drinks on one occasion?" [options: 1=Never / 2=Less than monthly / 3=Monthly / 4=Weekly / 5=Daily or almost daily]. The ordinal response will be analysed using proportional odds mixed-effects regression following the same analytic framework as the primary and secondary effectiveness analyses. Results will be interpreted in terms of direction and magnitude rather than formal hypothesis testing.

Baseline to 24 months
Effectiveness (other pre-specified): Frequency of cannabis use
Time Frame: Baseline to 24 months

Frequency of cannabis use among adolescents identified as high risk in schools randomised to PreVenture versus TAU, among students reporting any cannabis use in the past 12 months.

Among students reporting any cannabis use in the past 12 months, frequency of use will be assessed by asking "How often did you use cannabis in the last 12 months?" [options: 1=Monthly or less / 2=2-4 times per month / 3=2-3 times per week / 4=4-6 times per week / 5=Every day]. The ordinal response will be analysed using proportional odds mixed-effects regression following the same analytic framework as the primary and secondary effectiveness analyses. As this analysis is restricted to users only, it should be interpreted with caution as a selected subsample. Results will be interpreted in terms of direction and magnitude rather than formal hypothesis testing.

Baseline to 24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Patricia Conrod, PhD, St. Justine's Hospital
  • Principal Investigator: Jürgen Rehm, PhD, CAMH
  • Principal Investigator: Hayley Hamilton, PhD, CAMH
  • Principal Investigator: Marvin Krank, PhD, University of British Columbia
  • Principal Investigator: Sherry Stewart, PhD, Dalhousie University
  • Principal Investigator: Chris Richardson, PhD, University of British Columbia
  • Principal Investigator: David Smith, PhD, Interior Health BC
  • Principal Investigator: Joanna Henderson, PhD, CAMH

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2019

Primary Completion (Estimated)

April 1, 2026

Study Completion (Estimated)

April 1, 2026

Study Registration Dates

First Submitted

December 4, 2019

First Submitted That Met QC Criteria

December 11, 2019

First Posted (Actual)

December 13, 2019

Study Record Updates

Last Update Posted (Actual)

April 27, 2026

Last Update Submitted That Met QC Criteria

April 23, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Substance Use Disorders

Clinical Trials on PreVenture Training (PTtT)

Subscribe